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ABSTRACT 
Objective: The objective of this study was to prepare ceftriaxone sodium chitosan nanoparticles (CS-NP) from different drug and polymer ratios 
and analyze their physicochemical characteristics. 
Methods: Ceftriaxone sodium loaded chitosan nanoparticles were prepared using chitosan as a polymer and tri sodium polyphosphate (TPP) as 
cross linking agent by ionic cross linking and coacervation with the aid of sonication. Various trials have been carried out for the confirmation of 
nanoformulation. Parameters such as the zeta potential, polydispersity, particle size, entrapment efficiency, in vitro drug release Thermo 
gravimetric analysis and scanning electron microscope of the nanoparticles were assessed for confirmation of nanoformulation. 
Results: The formulated nanoparticles showed mean particle size, polydispersity index and zeta potential to be 183.1±8.42 nm, 0.212±0.05, 
+38.5±1.6 mV respectively and the drug loading was found to be 46.42±10 %. In vitro drug release was showed a biphasic release pattern with 
initial burst release followed by sustained release of formulated nanoparticles. The cumulative percentage of drug release was about 83.08 %. 
Conclusion: Formulation F2 was found to be the best formulation with a higher cumulative percentage of drug release. Modified ionic gelation 
method can be utilized for the development of chitosan nanoparticles of ceftriaxone sodium. Polymer and crosslinking agent concentrations and 
sonication time are rate-limiting factors for the development of the optimized formulation. The chitosan nanoparticles developed would be capable 
of sustained delivery of ceftriaxone sodium. 
Keywords: Ceftriaxone sodium, Chitosan nanoparticles, Zeta potential analysis, Scanning Electron Microscope Analysis, Particle size 




Ceftriaxone sodium is a semisynthetic antibiotic that can 
effectively treat several types of bacterial infections. It is a β-
lactamase-resistant cephalosporin with an extremely long serum 
half-life up to 4-to 10-times longer than the other antibiotics in 
this class. Because of its poor cellular penetration the effectiveness 
of antimicrobial treatment is limited especially third-generation 
cephalosporin. The poor cellular penetration of the antibiotic was 
associated to its high molecular weight (661.6 kg) as well as its 
hydrophilicity (log P 
Chitosan is a promising nano-carrier to release the encapsulated 
drug to the targeted tissues. Chitosan nanoparticles can be prepared 
by the interaction of oppositely charged macromolecules [3]. 
Compared with other biological polymers, chitosan is one of the 
most extensively used polymers. This is because chitosan possesses 
some ideal properties of polymeric carriers for nanoparticles such as 
biocompatible, biodegradable, nontoxic, and inexpensive [4]. The 
interaction can be controlled by the charge density of TPP and 
chitosan, which is dependent on the pH of the solution. Nano 
particulate systems show their promise as a potential ideal drug 
delivery system for poorly soluble, poorly absorbed and labile 
substances [5]. To overcome the limitation of synthetic drug, 
targeted drug delivery systems are designed. Nanoparticles have 
unique functional characters such as small particle size, high 
stability, lower toxicity, tuneable hydrophilic-hydrophobic balance 
and the ability to bear surface features for target specific 
localization, etc. The aim of the present study was to prepare and 
characterize ceftriaxone sodium loaded chitosan nanoparticles and 
produced release of ceftriaxone sodium. 
−0.6) [1].  
In recent years, it has become more and more evident that the 
development of new drugs alone is not sufficient to ensure 
progress in drug therapy. A promising strategy to overcome 
these problems involves the development of suitable drug 
carrier systems. Solid nanoparticles were introduced at the 
beginning of the 1990s, as an alternative to solid nanoparticles, 
emulsions and liposomes in cosmetic and pharmaceutical 
preparations [2-5]. 
MATERIALS AND METHODS  
Ceftriaxone sodium, chitosan (CS) (MW= 60–90 k Da; degree of 
deacetylation 85%) and sodium tripolyphosphate (TPP) were 
purchased from Sigma Aldrich, USA. All other chemicals were used 
analytical grade.  
Synthesis of ceftriaxone sodium CS-NP  
The chitosan–TPP nanoparticles were prepared via TPP ionic 
crosslinking and coacervation method as previously mentioned 
[8]. The chitosan nanoparticle synthesis procedure was first 
optimized at different concentrations of chitosan and the resulting 
mixtures were observed to be either clear, opalescent, or 
consisting of aggregates.  
The polymer was dissolved in 10 ml of 1% (v/v) acetic acid. The 
solution was continuously sonicated at room temperature and the 
pH of the solution was adjusted to 5.0 using 1 M NaOH. Ceftriaxone 
sodium at three different concentrations such as 25, 50 and 100 mg 
dissolved in water then added to the freshly prepared chi-tosan 
dispersion and stirred for 1 h. Finally, TPP (1 mg/ml) was added 
drop wise to the CS-ceftriaxone sodium solution under stirring 
(750rpm). 10. The resulting mixture was allowed to stir for 4 h to 
form ceftriaxone sodium encapsulated chitosan nanoparticles. All 
the process was carried out under room temperature. The 
synthesized nanoparticles were isolated by centrifugation. The 
formulations were then freeze-dried in the presence of 0.1% sucrose 
used as a cryoprotectant (Heto Drywinner, Thermo Scientific, USA) 
for 24 h at a pressure of 0.05 mmHg. The pellets were collected and 
stored at 4 °C for further use. 
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Table 1: Formulation design for the synthesis of ceftriaxone sodium loaded chitosan nanoparticles 
Formulation code Amount of drug (mg/ml) Amount of chitosan (mg) Amount of TPP (mg/ml) Drug+polymer ratio 
F1 10 10 0.25 1:1 
F2 10 20 0.25 1:2 
F3 10 30 0.25 1:3 
F4 10 40 0.25 1:4 
F5 10 50 0.25 1:5 
 
Percentage practical yield  
The practical yield of chitosan nanoparticles was calculated as follows:  
Percentage Yield =  weight of Lyophilized nanoparticle X 100
÷ Sum of initial dry weight of starting material 
Entrapment efficiency (EE) of nanoparticles 
The nanoparticles suspension was centrifuged at 15000 rpm for 30 
min. The supernatant solution was separated. 1 ml of supernatant 
was distributed in 10 ml distilled water and the absorbance was 
measured using a UV spectrophotometer at 240 nm using water as 
blank. The amount of drug unentrapped in the supernatant was 
calculated. The amount of drug entrapped was determined by 
subtracting amounts of free, uninterrupted drug from the total 
amount of ceftriaxone sodium taken [10-12].  
The drug entrapment efficiency (EE) of nanoparticles was calculated 
as follows:  
Entrapment Efficiency (%)  
=  Total amount of drug– unentrapped drug X 100
÷ Total amount of drug 
All measurements were performed in triplicate. 
In vitro drug release study 
In vitro drug release study was carried out with phosphate buffered 
solution (PBS) medium according to Dudhani and Kosaraju [18]. The 
release of ceftriaxone sodium chitosan nano formulation was 
determined using a modified dialysis membrane diffusion technique 
[13-17]. An accurately weighed amount of ceftriaxone sodium chitosan 
nano formulation equivalent to 50 mg of ceftriaxone sodium was 
transferred to a plastic cylinder having the length of 6 cm and 
diameter of 2.5 cm fitted at its lower end with dialysis membrane 
(Himedia dialysis membrane with the molecular cut off of 10 kDa) pre-
soaked with distilled water for 24 h. The cylinder was then suspended 
in the dissolution flask of a USP dissolution apparatus using 900 ml of 
phosphate buffer solution (pH 7.2) [19, 20]. The cylinder was allowed 
to rotate at a constant speed (25 rpm) at 37 °C±0.5. Aliquots were 
withdrawn and replaced with dissolution media and then the drug 
content was determined by measuring the absorbance values at 240 
nm using UV spectrophotometric method at predetermined time 
intervals for a total period of 24 h. All the operations were carried out 
in triplicate. And the release of ceftriaxone sodium was calculated from 
the following equations:  
Release rate (%)  = Released ceftriaxone sodium × 100
÷ Total ceftriaxone sodium 
UV–visible spectroscopy 
The UV–visible spectra were obtained from UV–visible 
spectrophotometer, Shimadzu UV-1800 model, Japan. All spectra 
were collected by recording between 200 and 800 nm and were 
corrected against chitosan as a background. 
Zeta sizer and zeta potential analysis 
The average particle size and zeta potential of the nanoparticles was 
determined using zeta sizer Nano series (Malvern Instrument, MAL 
1037088, USA). The measurement was carried with ultra-pure water 
using disposable zeta cells with the general purpose protocol at 25. 
The instrument was calibrated routinely with a −50 mV lat ex 
standard. The mean zeta potential was determined using phase 
analysis light scattering technique [22]. 
Scanning electron microscope analysis [23] 
The morphological features were examined by field emission-
scanning electron Microscopy FE-SEM), JEOL, JSM-6700F, Japan. The 
samples were sprinkled onto a double-sided tape and sputter coated 
with a 5 nm-thick gold layer [23]. 
FT-IR analysis 
The FT-IR spectra of the samples were analyzed using a Perkin-
Elmer, FT-IR spectrophotometer, USA within the range of 4000–400 
cm−1. About 5 mg of sample was mixed with 100 mg of KBr and 
compressed into pellet using a hydraulic press [24]. All spectra were 
corrected against the reference spectrum of KBr pellet. 
Thermo gravimetric analysis 
A Perkin-Elmer Model of TGA-7 thermo gravimetric system with a 
microprocessor driven temperature control unit and a TA data station 
was used. The mass of the samples was generally in the range of 2–3 mg. 
The sample pan was placed in the balance system equipment and the 
temperature was raised from 25 to 800 ᵒC at a heating rate of 10 ᵒC per 
min with the nitrogen flow rate of 50 cm 3
RESULTS AND DISCUSSION 
/min. The mass of the sample 
pan was continuously recorded as a function of temperature [25]. 
Synthesis of ceftriaxone sodium loaded chitosan nanoparticles 
Chitosan nanoparticles were synthesized by ionic cross linking and 
coacervation method with a chitosan to TPP ratio of 4:1 as reported in 
the literature [17]. The successful loading of ceftriaxone sodium CS-NP 
was optimized by varying the concentrations of ceftriaxone (10, 20, 40, 
80 and 100 mg) and was further confirmed by UV–visible 
spectrophotometry. Ceftiraxone in acetic acid solution gives major 
absorption bands at 259 nm indicating the presence of hydroxyl group 
and the lactone ring in its structure [21]. However, the UV–visible 
spectrum of the synthesized ceftriaxone sodium CS-NP exhibited 
absorption peak at 249 nm corresponds to the wavelength absorbed in 
Ceftriaxone sodium. This result indicates the successful loading of 
ceftriaxone within chitosan nanoparticles. Following the synthesis of 
ceftriaxone sodium CS-NP, their encapsulation and loading efficiency 
was calculated based on the UV–visible absorption spectral studies. As 
shown in table 2 the maximum encapsulation efficiency was 
determined by varying the concentration of ceftriaxone sodium in 
CS/TPP ratio (2:1). The polymer concentration of 20 mg showed high 
encapsulation 86.51±50. 
  
Table 2: Entrapment efficiency of ceftriaxone sodium into CS-NP determined by UV–visible spectrophotometry 
Formulation code (drug+polymer ratio) Entrapment efficiency 
F1(1:1) 65.59±30 
F2 (1:2) 86.51±50 
F3 (1:3) 66.81±40 
F4(1:4) 49.70±90 
F5 (1:5) 46.42±10 
Data’s are expressed as mean±SEM (n=3) 
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Particle size and zeta potential 
Particle size and surface charge are the major parameters to be 
focused to get effective drug delivery. fig. 1 (A) and table 3 depicts 
the average size distribution of the synthesized nanoparticles using 
Dynamic Light Scattering zeta sizer analysis. The average particle 
size of ceftriaxone sodium loaded chitosan nanoparticle is 249 nm. 
As shown in fig. 1 (B), the zeta potential value of ceftriaxone sodium 
loaded chitosan nanoparticle was 38.5 mV which indicates the 
nanoparticles to be stable. To allow efficient cell interaction and 
promote intracellular delivery of the chitosan nanoparticulate 
system, a high positive zeta potential is needed [28] Zeta potential 
measurement is an important index in determining the stability of 
the nanoparticle suspension.  
High absolute zeta potential value signifies high electric surface 
charge on the drug loaded nanoparticles, which can cause strong 
repellent forces among particles to prevent it from aggregation [29]. 
 
Table 3: Particle size poly dispersibility index and zeta potential of ceftriaxone sodium loaded CS-NP 
Formulation code Particle size (nm) (mean) Poly dispersibility index (mean) Zeta potential (mV) (mean) 
F1 271 0.021 42.6 
F2 249 0.012 38.5 
F3 309 0.213 46.2 
F4 311.6 0.417 47.5 
F5 345.3 0.434 44.7 
 
 
Fig. 1: (A) Particle size distribution of ceftriaxone sodium CS-NP 
 
 
Fig. 1: (B) zeta potential of ceftriaxone sodium CS-NP 
 
In vitro drug release study 
The release profile of ceftraxone sodium loaded nanoparticles into PBS 
(pH 7.4; 37 ᵒC) are shown in table 4, fig. 2(B). The in-vitro drug release 
study was performed Drug release from nanoparticles and micro 
particles occur by several mechanisms including surface erosion, 
disintegration, diffusion and desorption [21]. Ceftriaxone sodium 
loaded chitosan nanoparticles showed an initial release of 15.14% 
which may be accounted for the ceftriaxone adsorbed to the surface. 
Over 2 h, 83.03% of ceftriaxone sodium was released followed by slow 
release up to 24 h. The increased release in aqueous media from 
15.14% to 83.03% due to the swelling property of the polymer. 
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Table 4: In vitro release profiles of ceftriaxone sodium loaded CS-NP 
Time (min) Percentage of drug release for different batches of nano formulation 
F1 F2 F3 F4 F5 
0 0 0 0 0 0 
30 13.47±65 15.14±32 12.15±98 14.10±32 15.67±03 
45 25.61±89 27.83±25 22.40±43 26.40±25 28.19±68 
60 32.29±54 36.92±52 26.80±62 31.90±21 33.26±14 
120 40.45±74 47.09±45 32.00±51 39.00±24 40.21±19 
240 47.08±25 55.64±75 36.20±75 46.30±36 49.91±07 
360 52.93±21 62.75±95 40.50±64 53.20±37 57.24±15 
480 58.68±65 68.65±12 46.10±85 57.40±96 64.11±62 
600 65.18±78 72.88±23 49.20±53 60.20±85 69.64±35 
720 71.38±85 81.10±42 54.50±35 63.80±67 73.93±75 
1440 72.58±25 83.08±63 57.00±43 66.80±61 77.34±42 
Data’s are expressed as mean±SEM (n = 3) 
 
 
Fig. 2: (A) UV–visible spectrum of A-F1, B-F2, C-F3, D-F4, E-F5 
 
 
Fig. 2: (B) In vitro drug release profile for the formulation of ceftriaxone loaded CS-NP 
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Fig. 3: FT-IR spectrum of ceftriaxone sodium loaded–CS-NP 
 
FTIR studies for Ceftriaxone showed (fig. 3) characteristic peaks at 
3432.7 cm-1 (N-H stretching mode of H-bonded amide group), 
1741 cm-1 (β-lactam C=O stretching vibrations) and 1592 cm-1 
oxime C=N stretching vibrations). The spectrum of pure chitosan 
exhibited an amine deformation peak at 1600 cm-1 and amide I 
carbonyl stretch at 1643 cm-1
 
 (Samuels, 1981). The IR spectral 
interpretation shows that the spectra obtained from the 
formulation matches with original spectra of drug. Similarly 
characteristic peaks, for the polymers were also noticed in the 
formulation spectrum. There was no change of any characteristic 
peaks which confirms that the absence of chemical interaction 
between the drug and polymers. 
 
Fig. 4: Thermo gravimetric analysis of ceftriaxone loaded CS-NP 
 
The thermogravimetric analyzer (TGA) is an essential laboratory 
tool used for material characterization. TGA is a technique in which, 
upon heating a material, its weight increases or decreases. 
Thermogravimetric analysis (TGA) is a simple analytical technique 
which is used to study the thermal stability of the sample and their 
weight loss at different temperatures. It also confirms the successful 
loading of ceftriaxone sodium within CS-NP. We observed a four step 
decomposition patterns on ceftriaxone sodium loaded CS-NP (fig. 4). 
Initially, 39% weight loss was observed at 40.02◦C, due to the 
release of water molecules. The second step in the curve is about 
75% weight loss at 289.88◦
The morphology of the ceftriaxone sodium loaded chitosan nanoparticle 
was spherical in shape with their diameter roughly around 28 nm and 
was found to be aggregated. This is likely due to the fact that, as the 
particle size decreases they are liable to aggregate due to their high 
specific surface energy [24]. However, ceftriaxone sodium loaded 
chitosan fig. 5 shows distinct, spherical shaped particles with their 
average diameter around 30–250 nm This increased particle size could 
be due to the loading of ceftriaxone sodium chitosan nanoparticles 
similar results were observed in previous reports [25, 26]. 
C indicating the decomposition of CS and 
the third step was observed at 450 ᵒC with the weight loss of 19% 
could be due to the decomposition of both CS and ceftriaxone 
sodium. Finally the fourth step of decomposition was examined at 5 
35 ᵒC of about 09.79% which might be due to the decomposition of 
pure ceftriaxone sodium. Similar decomposition pattern of 
ceftriaxone was also observed in solid lipid nano particle and our 
result correlates well with this report. 
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Fig. 5: SEM image of ceftriaxone sodium loaded CS-NP 
 
CONCLUSION 
We have developed a method for synthesis of ceftriaxone loaded 
chitosan nanoparticle using ionic cross linking method. TPP used as a 
cross linking agent. The final formulation ratio of drug polimer is 1;2 
which act as an effective carrier with high loading efficiency. The 
bonding interactions between chitosan and ceftriaxone sodium were 
studied using FT-IR. The drug is released completely in phosphate buffer 
medium by 48 h at room temperature indicating sustained drug release 
pattern. SEM analysis revealed the spherical shaped morphology and the 
average particle size was 249. Finally we concluded that this method is 
reliable and reproducible less time consuming. 
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